OpenAlex
PricingAboutJobs
Log inGet started
Work

The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs

HTML

Year: 2012
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2011.40.3824
Authors: Saroj Niraula, Bostjan Seruga, Alberto Ocana, Tiffany Shao, Robyn Goldstein, Ian F. Tannock, Eitan Amir
Institutions: University of Toronto, Princess Margaret Cancer Centre, Institute of Oncology Ljubljana
Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions
Subfield: Toxicology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: anticancer agents, drug safety, serious adverse events, non-relapse mortality, treatment discontinuation, efficacy-toxicity trade-off, solid tumors, FDA-approved drugs, diarrhea, skin reactions, neuropathy, overall survival, progression-free survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2171154436
FWCI: 2.686
Cites: 68
Cited by: 174
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms